Early Adalimumab Leads to Better Outcomes for Psoriatic Arthritis Patients
Researchers found that, in this real-world clinical setting, patients with PsA who had a shorter disease duration achieved better results after treatment with adalimumab than did patients with a longer disease duration. This finding adds support to the idea that shorter symptom duration and earlier treatment with adalimumab could lead to a more favorable outcome in patients with PsA. Researchers did note, however, that further studies are needed to confirm these results.
Source: Early Adalimumab Leads to Better Outcomes for Patients With Psoriatic Arthritis
thumbnail courtesy of centerforbiosimilars.com
You can find more psoriasis and psoriatic arthritis news on our news page.
Additional reading: Lifestyle Changes to Manage Psoriasis – These Improvements Work!
The blog post Early Adalimumab Leads to Better Outcomes for Psoriatic Arthritis Patients is courtesy of: Mike Walker
Comments
Post a Comment